1. CXCR1 Regulates Pulmonary Anti-PseudomonasHost Defense
- Author
-
Carevic, M., Öz, H., Fuchs, K., Laval, J., Schroth, C., Frey, N., Hector, A., Bilich, T., Haug, M., Schmidt, A., Autenrieth, S.E., Bucher, K., Beer-Hammer, S., Gaggar, A., Kneilling, M., Benarafa, C., Gao, J.L., Murphy, P.M., Schwarz, S., Moepps, B., and Hartl, D.
- Abstract
Pseudomonas aeruginosais a key opportunistic pathogen causing disease in cystic fibrosis (CF) and other lung diseases such as chronic obstructive pulmonary disease (COPD). However, the pulmonary host defense mechanisms regulating anti-P. aeruginosaimmunity remain incompletely understood. Here we demonstrate, by studying an airway P. aeruginosainfection model, in vivo bioluminescence imaging, neutrophil effector responses and human airway samples, that the chemokine receptor CXCR1 regulates pulmonary host defense against P. aeruginosa. Mechanistically, CXCR1 regulates anti-Pseudomonasneutrophil responses through modulation of reactive oxygen species and interference with Toll-like receptor 5 expression. These studies define CXCR1 as a novel, noncanonical chemokine receptor that regulates pulmonary anti-Pseudomonashost defense with broad implications for CF, COPD and other infectious lung diseases.
- Published
- 2016
- Full Text
- View/download PDF